Post-approval studies (Phase 4)UnknownNCT05104437
What this trial is testing
Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes
Who this might be right for
COVID-19 Pneumonia
China National Biotec Group Company Limited 1,440